Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Beta Drugs Ltd

BETA.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$23.48

▼ -1.79%

Market Cap $260.30M · Vol 13.25K

Key Metrics

P/E Ratio

50.18

FWD: N/A

Market Cap

$260.30M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

35.58

Momentum

Beta

0.77

vs Market

52W High

$29.72

20.28% below

52W Low

$10.48

115.52% above

Volume

13.25K

Avg 37.48K

P/B

4.93

Price-to-book

ROE

N/A

Return on equity

Free Float

100.00%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Beta Drugs Ltd (BETA.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BETA.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.80%

-6.19%

+50.74%

+110.52%

YTD

+43.21%

+17.71%

+105.85%

+547.06%

Financials & Valuation

TTM · Annual

Total Revenue	$41.18M
Net Income	$4.44M
Revenue Growth (YoY)	+25.29%
Gross Margin	51.06%
Operating Margin	15.21%
Net Profit Margin	10.78%
ROE	N/A
ROA · ROIC	11.67% · 14.61%

P/E Ratio	50.18
Forward P/E (FY1)	N/A
PEG Ratio	-2.40
P/S	3.13
P/B	4.93
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	11.09M

Technical Indicators

50-Day SMA	$24.31
200-Day SMA	$17.52
RSI (14)	35.58
Beta	0.77
52-Week High	$29.72
52-Week Low	$10.48

Volume Today	13.25K
Avg Daily Volume (30D)	37.48K
Relative Volume	0.35x
Volatility (10D)	40.82
Volatility (30D)	57.79
Free Float	100.00%

Analyst Consensus

N/A

Current Price $23.48

Mean Target N/A

52W Low$10.48 52W High$29.72

Current

Target

$10.48 $29.72

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG00HVHP6B7

ISININE351Y01019

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -0.88% JNJ Johnson & Johnson -1.15% ABBV Abbvie Inc -1.44% NVS Novartis AG -1.90% NOVN.S Novartis AG -1.33%

Company Profile

Beta Drugs Limited is an India-based oncology medicine manufacturing company. The Company specializes in the intricate field of complex chemical synthesis for anti-cancer bulk drugs and finished dosages. The Company operates through one segment, Pharmaceuticals. Its product category includes cosmeceutical products and oncology products. The cosmeceutical products include La’Thrix, BACINOX, URTICALM, HUMIDA, NUSPLASH, UVIREX, ADVIBE, SENSIBAR, and RECAPRO. The oncology products include Temozad(Temozolomide), ADVIN(Vinorelbine), ADSIDE(Etoposide), ADRIB(Doxorubicin), ADCOV(Leucovorin calcium), ADPLATIN(Oxaliplatin), INOTAD(Irinotecan), ADCIST(Cisplatin), ADCARB(Carboplatin), ERLOTAD(Erlotinib), ADOXI(Docetaxel), AMGICIN(Gemcitabine), ADPAXIL(Paclitaxel), ADMIDE(Bicalutamide), and others. The Company's subsidiaries include Adley Lab Limited and Adley Formulations Private Limited.